CClinicalTrials.gg
CompletedNCT03281967Updated Mar 3, 2021

Clinical Survey of Minimally Invasive Ponto Surgical Technique (MIPS)

An interventional study of Minimally Invasive Ponto Surgery in Bone Conduction Deafness, Unilateral Deafness and Middle Ear Deafness, sponsored by Oticon Medical. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-03-03.

Sponsored by Oticon Medical · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The objective of the study is to compare the outcomes after a surgical procedure with minimally invasive Ponto surgery (MIPS, test group) and tissue preservation surgery (control) for placing Oticon Medical Ponto implants and abutments.

02

Conditions studied

  • Bone Conduction Deafness
  • Unilateral Deafness
  • Middle Ear Deafness
  • Mixed Hearing Loss
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years or older.
  • Patient indicated for an ear level bone anchored sound processor.
  • Healthy bone quality to allow for 4mm implant insertion.

Exclusion criteria

Exclusion Criteria:

  • Intraoperative switch to an alternative surgical technique
  • Patients undergoing re-implantation (on the side being included in the study)
  • Previous participation in the C47 study.
  • Inability to participate in follow-up.
  • Psychiatric disease in the medical history.
  • Mental disability.
  • Presumed doubt, for any reason, that the patient will be able to show up on all follow-ups.
  • Diseases or treatments known to compromise the bone quality at the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus.
  • Patients with natural skin height of >12mm (as there will be additional skin reduction needed)
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Other
    Minimally Invasive Ponto Surgery

    Surgical method for installation of a bone anchored hearing system for hearing rehabilitation

    Device: Minimally Invasive Ponto Surgery

Interventions

  • DeviceMinimally Invasive Ponto Surgery

    Minimally Invasive Ponto surgery is used for hearing rehabilitation using Ponto Wide Implant in patients indicated and counselled for Bone Anchored Hearing System.

05

What researchers measure

Primary outcomes

  1. Numbness (sensibility) around surgery area

    The primary objective of the study is to investigate the difference in numbness around implant after MIPS procedure (test, this investigation) and a surgery with soft tissue preservation (control, from a previous study, C47) for implanting Oticon Medical implants and abutments. Two different sensibilities will be tested by means of a broken wooden cotton swab/bud (q-tip): gnostic (with cotton side) and vital (with broken, sharp wooden side) sensibility. The measurement locations will be standardized at specific positions from surgery location, and the same location (with respect to the surgery site) will be used for sensibility measurement for each patient visit. Both the area (diameter in cm) and the degree (scale form 0 (no complaints) to 10 (maximum complaints)) will be monitored. Additionally, patients' subjective sensibility judgment around surgery area on a scale of 0-10 will be recorded.

    Time frame: 6 months post surgery

Secondary outcomes

  1. Time needed for surgery

    Compare the surgical time between test (this investigation) and control group (previous investigation, C47).

    Time frame: At surgery

  2. Unplanned visit

    Investigate and compare the number of unplanned visits, unplanned surgical procedures and other treatments for the test (this investigation) and control group (previous investigation, C47).

    Time frame: 36 months

  3. Adverse Events

    Investigate and compare the rate of adverse skin reactions using the Holgers Scale and the IPS scale.

    Time frame: 36 months

  4. Pain perception by patient

    Investigate and compare patient perceived pain. For pain measurement, the patient is asked if pain around the implant is present. If it's present, duration is assessed (more or less than 6 weeks present). In addition, increase of pain is assessed during manipulation of the abutment (tightening of or tapping on the abutment). The patient is asked to score the perceived pain on a scale of 0-10; with 0 being no pain at all and 10 being the highest pain the patient had ever experienced.

    Time frame: 36 months

  5. Implant survivability

    Investigate and compare implant survivability. Implant survivability is monitored by following upon patients and recording implant losses if and when they occur. The investigators do not expect multiple patients to have an implant loss. However, this may happen due to different reasons. The investigators would track the circumstances under which the implant loss occurred and the time between implant installation and loss.

    Time frame: 36 months

  6. Implant stability as measures by Implant stability quotient.

    Investigate implant stability.

    Time frame: 36 months

  7. Surgical wound healing time

    Investigate and compare healing time after surgery. Follow-up visits after surgery will assess the healing of wound. This will be a yes/no assessment to be answered by the attending physician. The investigators will also evaluate skin reactions using the Holgers Scoring Scheme and record any medications that were given to aid in skin healing.

    Time frame: 36 months

  8. Quality of Life Assessment

    Investigate and compare subjective benefit as measured by APHAB, GBI and GHSI questionnaires.

    Time frame: 36 months

  9. Aesthetic Assessment

    Investigate and compare scar assessment by surgeon and patient (POSAS).

    Time frame: 36 months

06

Study locations

1 site
  • University Medical Center St Radboud
    Nijmegen, 6500, Netherlands
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03281967
Lead sponsor
Oticon Medical
Responsible party
Sponsor
First posted
Sep 13, 2017
Start date
Jun 9, 2017
Primary completion
Jun 13, 2018
Completion
Dec 21, 2020
Last update
Mar 3, 2021

Study contacts

Myrthe Hol, MD, PhD
principal investigator · Radboud UMC, Department of Otorhinolaryngology. The Netherlands

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion